Back
Brookfield Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
46
BN
Brookfield
Last Price:
$51.81
Seasonality Move:
2.94%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
46
Brookfield (BN)
is a Sell
Is Brookfield a Buy, Sell or Hold?
-
The current Brookfield [BN] share price is $51.85. The Score for BN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
BN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BN Stock Price Chart
What is Brookfield's stock price today?
-
The Brookfield share price today is $51.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BN is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
BN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.9 | Sell |
Relative Strength Index (14 RSI): | 40.69 | Sell |
Chaikin Money Flow: | -4856437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.27 - 57.11) | Sell |
Bollinger Bands (100): | (54.36 - 60.2) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 78938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.82 - 268.04) | Buy |
Bollinger Bands (100): | (240.65 - 270.25) | Buy |
BN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.05 | Sell |
20-day SMA: | 53.18 | Sell |
50-day SMA: | 56.87 | Sell |
200-day SMA: | 52.53 | Sell |
8-day EMA: | 53.51 | Sell |
20-day EMA: | 54.03 | Sell |
50-day EMA: | 55.6 | Sell |
200-day EMA: | 52.68 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 271.33 | Sell |
20-day SMA: | 255.41 | Buy |
50-day SMA: | 259.88 | Buy |
200-day SMA: | 253.94 | Buy |
8-day EMA: | 268.64 | Sell |
20-day EMA: | 261.32 | Buy |
50-day EMA: | 257.88 | Buy |
200-day EMA: | 244.57 | Buy |
Brookfield Earnings Growth & BN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $0.78 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Brookfield Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |